The company reinforces its role within Spain’s MedTech ecosystem as part of its growth and international expansion strategy
Madrid, Spain — 2EyesVision, a company specialized in visual simulation technologies applied to ophthalmology, announces its incorporation into Fenin, the Spanish Federation of Healthcare Technology Companies, the leading organization representing the MedTech sector in Spain.
This milestone marks a significant step in the company’s evolution, aligned with its growth, consolidation, and international expansion strategy. Becoming part of Fenin will enable 2EyesVision to strengthen its institutional presence, contribute to the advancement of the sector, and actively collaborate in initiatives that promote technological innovation in healthcare.
What is Fenin?
The Spanish Federation of Healthcare Technology Companies (Fenin) is the main organization representing the MedTech industry in Spain. It serves as a key bridge between companies, public administrations, and healthcare institutions, promoting innovation and improving the quality and efficiency of the healthcare system. Fenin supports the adoption of advanced medical technologies, encourages best practices, and plays a central role in regulation, internationalization, and knowledge generation. Through its working groups and initiatives, it fosters collaboration across the ecosystem, helping drive the transformation of healthcare and ensuring better access to innovative solutions for professionals and patients.
Strategic implications
By joining Fenin, 2EyesVision reinforces its commitment to shaping the future of ophthalmology through innovation, collaboration, and clinical excellence. This step positions the company within a network of leading healthcare technology players, opening new opportunities for partnerships, knowledge exchange, and market expansion. For clinicians, it means continued access to cutting-edge tools that improve decision-making and patient outcomes. For partners and institutions, it reflects a company aligned with industry standards, actively contributing to the evolution of healthcare. For investors, it signals maturity, credibility, and integration within a key strategic ecosystem driving MedTech growth in Spain and beyond. 2EyesVision continues to advance its mission of bringing innovative solutions closer to eyecare professionals and patients, enabling more informed clinical decisions and enhancing the pre-surgical experience.
“Joining Fenin is an opportunity to help shape the future of healthcare technology in Spain from within the ecosystem—sharing knowledge and contributing to a more precise, personalized, and evidence-based ophthalmology” said Carlos Dorronsoro, CEO of 2EyesVision.
This membership also strengthens the company’s commitment to quality standards, sector collaboration, and the development of a more innovative and sustainable healthcare environment.
Want to learn more about 2EyesVision updates?
Discover more news and insights on EyesVision
